Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer

The current study was performed to longitudinally assess the impact of adjuvant treatments on the quality of life (QoL) of elderly colorectal cancer survivors.

[1]  G. Launoy,et al.  Trends in incidence of digestive cancers in France , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  Philip Rubin,et al.  TNM Staging Atlas , 2007 .

[3]  N. Laird,et al.  Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. , 1997, Statistics in medicine.

[4]  G. Launoy,et al.  Trends in the management and survival of digestive tract cancers among patients aged over 80 years , 2005, Alimentary pharmacology & therapeutics.

[5]  J. Coebergh,et al.  Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[7]  G. Launoy,et al.  Incidence of gastrointestinal cancers in France. , 2004, Gastroenterologie clinique et biologique.

[8]  D. Fairclough,et al.  Evaluation of quality of life in a clinical trial with nonrandom dropout: The effect of epoetin alfa in anemic cancer patients , 2003, Quality of Life Research.

[9]  A. Zaslavsky,et al.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Pauler,et al.  Pattern mixture models for longitudinal quality of life studies in advanced stage disease , 2003, Statistics in medicine.

[11]  A. Neugut,et al.  Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Faivre-Finn,et al.  Chemotherapy for colon cancer in a well‐defined French population: is it under‐ or over‐prescribed? , 2002, Alimentary pharmacology & therapeutics.

[13]  M. Usel,et al.  Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice , 2001, British Journal of Cancer.

[14]  A. Neugut,et al.  Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. , 2001, Cancer journal.

[15]  C. Faivre-Finn,et al.  Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  D. Cella,et al.  Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. , 1998, Statistics in medicine.

[17]  B. Jeppsson,et al.  Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer , 1997, Supportive Care in Cancer.

[18]  D. Osoba.  Lessons learned from measuring health-related quality of life in oncology. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Aaronson,et al.  Critical review of the international assessments of health-related quality of life , 1993, Quality of Life Research.

[20]  P. Newcomb,et al.  Cancer treatment and age: patient perspectives. , 1993, Journal of the National Cancer Institute.

[21]  G. Padilla,et al.  Health quality of life and colorectal cancer , 1992, Cancer.

[22]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[23]  L. Påhlman,et al.  Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. , 1990, Annals of surgery.

[24]  T. Fleming,et al.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  T. Anthony,et al.  The Effect of Treatment for Colorectal Cancer on Long-Term Health-Related Quality of Life , 2001, Annals of Surgical Oncology.

[26]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Mainguet,et al.  Prévention, dépistage et prise en charge des cancers du côlon , 1998 .

[28]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[29]  A. Dobson,et al.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.